Notice of Participation in a Project Selected for AMED’s FY2026 "Medical-Engineering Collaboration and Artificial Intelligence Implementation Research Project"

Sep 24

1 min read

We are pleased to announce that our joint research project, conducted in collaboration with the University of the Ryukyus, Tokushima University, Kyushu University, Hokkaido University, and Kitasato University, has been selected for the Fiscal Year 2026 "Medical-Engineering Collaboration and Artificial Intelligence Implementation Research Project" funded by the Japan Agency for Medical Research and Development (AMED).

Project Title:

"Development of an Integrated Safety Net Software as a Medical Device (SaMD) Utilizing AI for Early Detection of Heart Failure Worsening and Support for Clinical Decision-Making by Non-Specialists"

Program Objective:

This program promotes the development and practical social implementation of AI services and medical products within the healthcare field.

Project Overview & Funding Details:

•Focus Area: Development of AI services or AI products aimed at reducing the workload of healthcare professionals.

•Planned R&D Period: August 2026 (tentative) – End of FY2029.

■ For more details

https://www.u-ryukyu.ac.jp/news/96553/

■Contact Information

info@southwood.co.jp

Comments

Notice of Participation in a Project Selected for AMED’s FY2026 "Medical-Engineering Collaboration and Artificial Intelligence Implementation Research Project"

Sep 24

Change of Manufacturer and Distributor for the Butterfly iQ3™

Southwood Inc. (Headquarters: Tokushima City, Tokushima Prefecture; Representative Director: Tomoki Kurosawa) announces that the manufacturer and distributor of the Butterfly iQ3™, a portable ultrasound imaging device manufactured by Butterfly Network, Inc., USA, has been changed from Premo Partner Co., Ltd. (Headquarters: Chuo City, Tokyo) to Southwood Inc. Premo Partner Co., Ltd. obtained Class II medical device certification for the Butterfly iQ3™ in Japan and had been m

Sep 1

Southwood to Exhibit at Three Upcoming Ultrasound Scientific Meetings

We are pleased to announce that our company will exhibit at the following scientific meetings, which will be held at Tokyo International Forum from May 29–31, 2026. ________________________________________ ■ The 18th Annual Meeting of the Japanese Society of Point-of-Care Ultrasound Dates: May 30 (Sat) – May 31 (Sun), 2026 Venue: Tokyo International Forum Official Website: https://lycoris.info/jpocus18/ ________________________________________ ■ The 99th Annual Scientific Mee

May 18

We Have Obtained ISO 13485：2016 Certification

Our company has obtained certification for the international standard ISO 13485：2016, a quality management system standard specific to the medical device industry, on March 30, 2026 . ISO 13485：2016 provides the foundation for quality management practices in medical device regulations worldwide, including those in Japan. We will continue to strengthen our quality management system while advancing digital transformation in healthcare. ■ ISO 13485：2016 Certification Regis

Apr 6

We Have Obtained “Certification for a Designated Specially Controlled Medical Device.”

On March 11, 2026, our company obtained the “Certification of Designated Specially Controlled Medical Devices.” We are dedicated to accelerating the integration of AI-assisted ultrasound diagnostics into the healthcare system. ■ Details of the “Certification of Designated Specially Controlled Medical Devices.” Certification Number: 308ACBZX00005000 Marketing Authorization Holder: Southwood Inc. Certified Product: Ultrasound Image Display Software “Southwood” Certification Dat

Mar 31

A Pilot Study on Remote Ultrasound Using the “Butterfly iQ3™” Was Conducted

Southwood Inc. (Headquarters: Tokushima City, Tokushima Prefecture; Representative Director: Kenya Kusunose), a licensed distributor of the portable ultrasound diagnostic device “Butterfly iQ3™” manufactured by Butterfly Network, Inc. (U.S.), conducted a remote echocardiography demonstration (pilot study) on March 6, 2026, at University of the Ryukyus Hospital and Okinawa Prefectural Yaeyama Hospital, with real-time connectivity between both locations. In this pilot study of

Mar 17